Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
03 May 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_FWN4140WS:0-ajanta-pharma-says-us-fda-issues-form-483-with-5-observations-at-ajanta-pharma-paithan-facility/